|
|
조선살
|
|
 |
xrOvclXxHsqjv |
 |
402 |
|
 |
| Pleased to meet you http://genericlevitra.in.net/ levitra 20mg Now approved to treat liver and kidney cancer, Nexavar brought in €792 million last year, about $900 million. Its sales for the first half of this year amounted to €373 million, a bit less than the same period last year. So, new uses are key for continued growth. The thyroid cancer approval would be a help, but Bayer and Onyx had really hoped for a new indication in lung cancer, the third most common type of cancer in the U.S. That study fell short last year. |
|
 |
Mohamed |
 |
2020-01-28 23:22:24 |
|
|
|
|
|
|
|
|
|
